September 14, 2021
APC cautions against making claims of efficacy about drugs prescribed for off-label use
APC applauds the heroic efforts of pharmacy compounders who continue to provide patients with access to vaccines and a wide variety of treatment options during the ongoing Covid-19 pandemic.
APC does not endorse any particular prescribed drugs or treatment for Covid-19 that meet the standard of care and satisfy all applicable federal and state statutes and rules. As set forth in APC’s Pharmacy Compounding Professional’s Code of Ethics, we continue to encourage compounders to uphold the triad relationship among patients, prescribers, and pharmacists and to work collaboratively in determining the course of treatment that is in the patient’s best interest. In making such decisions, pharmacists should exercise their professional judgment and remember that patient safety is always of paramount importance.
APC strongly cautions compounders against making claims of efficacy with respect to any drug that has not undergone the FDA’s premarket approval process or that is being prescribed for an off-label use.
